Albemarle Corporation revised earnings guidance for the year 2022. The company announced improved full-year 2022 guidance primarily due to the completion of additional lithium contract renegotiations. The company now expects net sales to be in the range of $5.8 billion to $6.2 billion compared to previous guidance of $5.2 billion to $5.6 billion.